Claire Gorry retweeted
The use of HTA to inform @MedMgmtProg health technology management processes - excellent insight on life-cycle approach to drug reimbursement by @gorrycm #ISPOREurope
Claire Gorry retweeted
Universal childhood varicella vaccination is cost effective in Ireland based on a great poster from Susan Ahern from HIQA
#ISPOREurope
Claire Gorry retweeted
The NCPE have completed a Rapid Review of Tebentafusp (Kimmtrak®) as monotherapy for the treatment of human leukocyte antigen (HLA)-A*02:01-positive adult patients with unresectable or metastatic uveal melanoma. (1/2)
Claire Gorry retweeted
Dr Caroline Walsh is presenting on her study completed in collaboration with @TrinityMed1 students on surrogate measures/benefit categories of EMA approved cancer drugs and recommendations made by the NCPE @INFO_NCPE #ISPOREurope
Great presentation by @KarenFinnigan2 on Applications for Tolvaptan under a Managed Access Protocol in Ireland, lots of interest and great questions. The poster was in the top 5% of research abstracts presented at #ISPOREurope this year!
Claire Gorry retweeted
Karen Finnigan providing an overview of applications for tolvaptan under a Managed Access Protocol in Ireland 📊 this poster was in the top 5% of submitted posters 🏆
Claire Gorry retweeted
Very proud of the @MedMgmtProg team today at #ISPOREurope. Oral presentations today from @BernardDuggan and @KarenFinnigan2 and tomorrow from @gorrycm and 6 posters to present also @amelia_epi. A busy day & well done to the whole team 👏
The MMPs Dr Amelia Smith's poster on Health Technology Management as the future of the post-reimbursement phase for medicines on display at #ISPOREurope , board 4036 from 10.30 today!
An overview of Baseline Characteristics of Patients Approvers for Reimbursement of Liraglutide for Weight Management under a Managed Access Protocol in Ireland is presented at #ISPOREurope , board 3054 from 10.30 am this morning!
MMP research on Utilisation and Expenditure on Blood Glucose Test Strips and the Impact of Cost Containment Measures on display at #ISPOREurope , call by during the presentation hour starting at 12.30 today
Research by the @MedMgmtProg MMP's Sinead Lucey on Applications for Tafamidis under a Managed Access Protocol in Ireland, will be on display at #ISPOREurope , poster 3055, from 10.30 today
Claire Gorry retweeted
Karen Finnigan giving an update on the Managed Access Protocol for CGRP mAbs in Ireland 📊 at the Cost Containment session #ISPOREurope
Claire Gorry retweeted
Bernard Duggan provides an update on the highly successful Best Value Biological initiative in Ireland 📈 📍at the RWE case study session #ISPOREurope
Astonishing turnaround in biosimilar uptake in Ireland as a result of the 'best value biologicals' initiative, well done to all in @MedMgmtProg
Claire Gorry retweeted
Excited to be at my first in-person ISPOR conference today. Looking forward to presenting my poster on the quality of clinical evidence in oncology HTA submissions at the second poster session later ! #ISPOREurope
Claire Gorry retweeted
Delighted to be at #ISPOREurope to present a project we @INFO_NCPE did with @TrinityMed1 2nd year Med students earlier this year as part of our @tcddublin research & teaching commitments.
Presenting at poster board 4063 between 3.30-6.30pm today
Claire Gorry retweeted
Here in Copenhagen for #ISPOREurope 📊 come and see my poster summary of Health Technology Management at the 'Health Service Delivery & Process of Care' poster category. 🔍 – at Copenhagen, Denmark
Claire Gorry retweeted
Excited to be in Copenhagen for #ISPOREurope - a busy few days of oral presentations, poster presentations, and networking. We'll be highlighting some of the many Health Technology Management strategies that underpin the work of the MMP.
Claire Gorry retweeted
We’re at ISPOR Europe 2023! Several of our staff will be speaking at plenary sessions and presenting posters over the next few days #ISPOREurope
Looking forward to seeing @BernardDuggan presenting this morning at #ISPOREurope on Ireland's Best Value Biologicals initiative.

































